Stephan Walz
Vermögen: 200 000 $ am 31.07.2026
Vermögen: 200 000 $ am 31.07.2026
Stephan Walz is the founder of Aristo Pharma GmbH, serving as Chief Executive Officer since its founding in 2008.
Current jobs include Managing Director at Passauer Pharma GmbH since 2019 and Independent Non-Executive Director at BM3EAC Corp.
Former jobs include Chief Executive Officer at Invent Invest Holding SL, Chief Executive Officer at neuraxpharm Arzneimittel GmbH from 2016 to 2018, Director at Albrecht, Prock & Partners AG, Director at 3w Beratungs- Und Beteiligungs GmbH, and Head-Production & Development at Lindopharm GmbH.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
BM3EAC CORP. 0,32 % | 31.12.2024 | 20.000 ( 0,32 % ) | 200 000 $ | 31.07.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| BM3EAC CORP. | Direktor/Vorstandsmitglied | - |
Passauer Pharma GmbH
Passauer Pharma GmbH Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Vorstandsvorsitzender | 01.11.2019 |
| Unternehmen | Position | Ende |
|---|---|---|
neuraxpharm Arzneimittel GmbH
neuraxpharm Arzneimittel GmbH Pharmaceuticals: GenericHealth Technology Manufactures pharmaceutical products for central nervous system disorders | Vorstandsvorsitzender | 05.09.2018 |
Albrecht Prock & Partners AG
Albrecht Prock & Partners AG Miscellaneous Commercial ServicesCommercial Services Operates as a strategy consultancy and advisory firm that specializes in M&A assistance, strategy development, operations and talent management | Direktor/Vorstandsmitglied | - |
3w Beratungs- Und Beteiligungs GmbH | Direktor/Vorstandsmitglied | - |
Aristo Pharma GmbH
Aristo Pharma GmbH Pharmaceuticals: MajorHealth Technology Manufactures and distributes sought-after active ingredients | Vorstandsvorsitzender | - |
Lindopharm GmbH
Lindopharm GmbH Pharmaceuticals: MajorHealth Technology Produces human and veterinary drugs, as well as food supplementary products | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 8 |
|---|---|
Lindopharm GmbH
Lindopharm GmbH Pharmaceuticals: MajorHealth Technology Produces human and veterinary drugs, as well as food supplementary products | Health Technology |
Invent Invest Holding SL
Invent Invest Holding SL Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals | Health Technology |
neuraxpharm Arzneimittel GmbH
neuraxpharm Arzneimittel GmbH Pharmaceuticals: GenericHealth Technology Manufactures pharmaceutical products for central nervous system disorders | Health Technology |
Aristo Pharma GmbH
Aristo Pharma GmbH Pharmaceuticals: MajorHealth Technology Manufactures and distributes sought-after active ingredients | Health Technology |
Albrecht Prock & Partners AG
Albrecht Prock & Partners AG Miscellaneous Commercial ServicesCommercial Services Operates as a strategy consultancy and advisory firm that specializes in M&A assistance, strategy development, operations and talent management | Commercial Services |
Passauer Pharma GmbH
Passauer Pharma GmbH Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
BM3EAC Corp.
BM3EAC Corp. Financial ConglomeratesFinance Operates as a special purpose acquisition company | Finance |
3w Beratungs- Und Beteiligungs GmbH |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen